MEDTOX Scientific, Inc. Is Investigated by Faruqi & Faruqi, LLP for Potential Breaches of Fiduciary Duties by Its Board of Di...

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of MEDTOX Scientific, Inc. (“MEDTOX” or the “Company”) (NASDAQ: MTOX) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Laboratory Corporation of America® Holdings (NYSE: LH) in an all-cash deal valued at about $241 million. Under the terms of the proposed transaction, MEDTOX stockholders will receive $27.00 in cash for each share of MEDTOX common stock they own.

Request more information now by clicking here: www.faruqilaw.com/MTOX. There is no cost or obligation to you.

Whether the Board of Directors of MEDTOX breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether the proposed transaction undervalues MEDTOX shares and by how much this proposed transaction undervalues the Company to the detriment of MEDTOX shareholders are the key focus of this investigation.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in MEDTOX and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/MTOX or contact Juan E. Monteverde, Esq. either via e-mail at [e-mail] or by telephone at [phone] or [phone].

Attorney Advertising. (C) 2012 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.